$AZN News and Market Events
Every $AZN story Market Flux has tracked.
- Market Flux Event
Myriad Genetics and SOPHiA GENETICS Team Up With AstraZeneca to Develop Prostate Cancer Genomic Instability Score Technology
Myriad Genetics and SOPHiA GENETICS announced on October 8, 2026 a new collaboration to develop and advance prostate cancer-specific genomic instability score (PrGIS) technology, with…
- Top Mover
Leerink Partners Cuts Bristol-Myers Squibb to Market Perform, Slashes Price Target to $59 on Pipeline Doubt
Leerink Partners downgraded Bristol-Myers Squibb from Outperform to Market Perform on October 5, cutting its price target to $59 from $73. Analyst David Risinger cited growing skepticism…
- Market Flux Event
FDA Grants Accelerated Approval to AstraZeneca's Breast Cancer Pill Etcamah for ESR1-Mutated Tumors
The U.S. Food and Drug Administration has granted accelerated approval to AstraZeneca's camizestrant, branded as Etcamah, for the treatment of hormone receptor-positive, HER2-negative…
- Market Flux Event
Trump Announces Drug Pricing Deals With Nine More Pharma Companies, Expanding Most Favored Nation Push
President Trump announced on August 31 that his administration has struck drug pricing agreements with nine additional pharmaceutical and biotech companies, committing them to sell…
- Market Flux Event
FDA Expands Mounjaro Label to Reduce Heart Attack and Stroke Risk in Type 2 Diabetes Patients
The FDA approved an expanded label for Eli Lilly's Mounjaro (tirzepatide) to reduce major adverse cardiovascular events, including heart attack and stroke, in high-risk patients with type 2…